SCHEMBL14806709

SCHEMBL14806709

O=C(O)c1ccc2cc3cccnc3cc2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.60
▸ KDM4E B2RXH2 4/20 0.60
▸ MEN1 O00255 3/20 0.60
▸ LMNA P02545 2/20 0.60
▸ MGAM O43451 1/20 0.56
▸ ALDH1A1 P00352 4/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ MCL1 Q07820 1/20 0.46
▸ NPC1 O15118 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HTT P42858 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ NR4A2 P43354 1/20 0.43
▸ NAPRT Q6XQN6 1/20 0.43
▸ P4HTM Q9NXG6 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ALOX15 P16050 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9220609 0.86 MGAM (0.61) KMT2AKDM4EMEN1LMNAMGAM
SCHEMBL12501532 0.82 MGAM (0.69) KMT2AKDM4EMEN1LMNAMGAM
Quinaldic Acid SCHEMBL22449357 0.81 MGAM (0.79) KMT2AKDM4EMEN1LMNAMGAM
SCHEMBL1416035 0.81 ALDH1A1 (0.56) KMT2AKDM4EMEN1LMNAMGAM
SCHEMBL13415774 0.80 ALDH1A1 (0.47) KMT2AKDM4EMEN1LMNAALDH1A1
Quinaldic Acid SCHEMBL27607370 0.80 MGAM (0.77) KMT2AKDM4EMEN1LMNAMGAM
SCHEMBL12405037 0.80 MGAM (0.63) KMT2AKDM4EMEN1LMNAMGAM
SCHEMBL841536 0.79 ALDH1A1 (0.61) KMT2AKDM4EMEN1LMNAMGAM
SCHEMBL6647315 0.78 NPC1 (0.62) KMT2AKDM4EMEN1LMNAALDH1A1
Hydrochloric Acid SCHEMBL27619882 0.77 ALDH1A1 (0.59) KMT2AKDM4EMEN1LMNAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267693-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2017-09-21 — — US disclosed
US-8410103-B2 (3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agent SHIONOGI & CO., LTD. (JP) 2013-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267693-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY NR4A1, NCOA4, NR4A2 KMT2A 390/4885KDM4E 257/4885MEN1 4533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback